AMBER FIGUEROA: Open Payments
NPI 1518733401 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Novo Nordisk Inc | 4 | $81 |
| Verona Pharma, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Optinose US, Inc. | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
Products named: AIRSUPRA, Rybelsus, Ohtuvayre, AREXVY, PREVNAR 20, JARDIANCE, Xhance, CONTRAVE.
Industry payments across NY — which companies pay providers there.
